Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bousquet

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Metabolic Syndrome and Related Disorders|December 9, 2016
Cerebral Microvascular Dysfunction and Inflammation Are Improved by Centrally Acting Antihypertensive Drugs in Metabolic SyndromeVanessa Estato, Alessandro Nascimento, Barbara Antunes, et al.
L' Orthodontie Francaise|December 18, 2007
[Genetic origin of non-syndromic cleft lip and palate. TWIST, a candidate gene? Research protocol]William Bacon, Pascal Tschill, Bruno Grollemund, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2007
sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heartLaurent Monassier, Boris Manoury, Chloé Bellocq, et al.
Plos One|January 5, 2011
Constitutive overexpression of muscarinic receptors leads to vagal hyperreactivityAngelo Livolsi, Nathalie Niederhoffer, Nassim Dali-Youcef, et al.
British Journal of Pharmacology|June 5, 2004
LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptorsDragan Urosevic, Urosevic Dragan, Stephan Schann, et al.
Microcirculation (New York, N.Y. : 1994)|April 19, 2016
Central Sympathetic Modulation Reverses Microvascular Alterations in a Rat Model of High-Fat Diet-Induced Metabolic SyndromeAlessandro R Nascimento, Marcus V Machado, Fabiana Gomes, et al.
Bioorganic & Medicinal Chemistry|July 4, 2012
Methylation of imidazoline related compounds leads to loss of α₂-adrenoceptor affinity. Synthesis and biological evaluation of selective I₁ imidazoline receptor ligandsStephan Schann, Hugues Greney, Vincent Gasparik, et al.
International Journal of Obesity (2005)|March 31, 2019
Effects of imidazoline-like drugs on liver and adipose tissues, and their role in preventing obesity and associated cardio-metabolic disordersGaëlle Aubertin, Maud Weiss, Florian Traversi, et al.
Journal of Medicinal Chemistry|January 5, 2002
Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazoleFrancesco Gentili, Pascal Bousquet, Livio Brasili, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 3, 2013
A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in ratsLyne Fellmann, Véronique Regnault, Hugues Greney, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Metabolic Syndrome and Related Disorders|December 9, 2016
Cerebral Microvascular Dysfunction and Inflammation Are Improved by Centrally Acting Antihypertensive Drugs in Metabolic SyndromeVanessa Estato, Alessandro Nascimento, Barbara Antunes, et al.
L' Orthodontie Francaise|December 18, 2007
[Genetic origin of non-syndromic cleft lip and palate. TWIST, a candidate gene? Research protocol]William Bacon, Pascal Tschill, Bruno Grollemund, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2007
sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heartLaurent Monassier, Boris Manoury, Chloé Bellocq, et al.
Plos One|January 5, 2011
Constitutive overexpression of muscarinic receptors leads to vagal hyperreactivityAngelo Livolsi, Nathalie Niederhoffer, Nassim Dali-Youcef, et al.
British Journal of Pharmacology|June 5, 2004
LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptorsDragan Urosevic, Urosevic Dragan, Stephan Schann, et al.
Microcirculation (New York, N.Y. : 1994)|April 19, 2016
Central Sympathetic Modulation Reverses Microvascular Alterations in a Rat Model of High-Fat Diet-Induced Metabolic SyndromeAlessandro R Nascimento, Marcus V Machado, Fabiana Gomes, et al.
Bioorganic & Medicinal Chemistry|July 4, 2012
Methylation of imidazoline related compounds leads to loss of α₂-adrenoceptor affinity. Synthesis and biological evaluation of selective I₁ imidazoline receptor ligandsStephan Schann, Hugues Greney, Vincent Gasparik, et al.
International Journal of Obesity (2005)|March 31, 2019
Effects of imidazoline-like drugs on liver and adipose tissues, and their role in preventing obesity and associated cardio-metabolic disordersGaëlle Aubertin, Maud Weiss, Florian Traversi, et al.
Journal of Medicinal Chemistry|January 5, 2002
Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazoleFrancesco Gentili, Pascal Bousquet, Livio Brasili, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 3, 2013
A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in ratsLyne Fellmann, Véronique Regnault, Hugues Greney, et al.
Pageof 5